54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 07
19:34 UTC
|
MFC
Manulife Financial
|
◎ Target | firm only | Outperform | C$55.00→ C$67.00+21.8% |
|
Aug 07
19:34 UTC
|
MFC
Manulife Financial
|
◎ Target | firm only | Buy | C$63.00→ C$68.00+7.9% |
|
Aug 07
19:34 UTC
|
LUN
Lundin Mining
|
◎ Target | firm only | Buy | C$43.00→ C$42.00-2.3% |
|
Aug 07
19:34 UTC
|
KXS
Kinaxis
|
◎ Target | firm only | Outperform | C$195.00→ C$200.00+2.6% |
|
Aug 07
19:34 UTC
|
KXS
Kinaxis
|
◎ Target | firm only | Outperform | C$200.00→ C$210.00+5.0% |
|
Aug 07
19:34 UTC
|
KMP.UN
Killam Apartment REIT
|
◎ Target | firm only | Sec→ r Outperform | C$20.00→ C$20.25+1.2% |
|
Aug 07
19:34 UTC
|
KMP.UN
Killam Apartment REIT
|
◎ Target | firm only | Outperform | C$21.00→ C$21.25+1.2% |
|
Aug 07
19:34 UTC
|
KMP.UN
Killam Apartment REIT
|
◎ Target | firm only | Buy | C$21.00→ C$22.00+4.8% |
|
Aug 07
19:34 UTC
|
KEY
Keyera
|
◎ Target | firm only | C$56.00→ C$61.00+8.9% | |
|
Aug 07
19:34 UTC
|
IOVA
Iovance Biotherapeutics
|
◎ Target | Etzer Darout ★★★☆☆ #1059 | Overweight | $11.00→ $13.00+18.2% |
|
Aug 07
19:34 UTC
|
IFF
International Flavors & Fragrances
|
◎ Target | Lauren Lieberman ★★★☆☆ #1047 | Overweight | $90.00→ $96.00+6.7% |
|
Aug 07
19:34 UTC
|
GRT.UN
Granite Real Estate Investment Trust
|
◎ Target | firm only | Outperform | C$110.00→ C$106.00-3.6% |
|
Aug 07
19:34 UTC
|
GRT.UN
Granite Real Estate Investment Trust
|
◎ Target | firm only | Buy | C$106.00→ C$108.00+1.9% |
|
Aug 07
19:34 UTC
|
GRT.UN
Granite Real Estate Investment Trust
|
◎ Target | firm only | Buy | C$101.00→ C$103.00+2.0% |
|
Aug 07
19:34 UTC
|
GLUE
Monte Rosa Therapeutics
|
◎ Target | Brian Cheng ★★☆☆☆ #2424 | Overweight | $31.00→ $27.00-12.9% |
|
Aug 07
19:34 UTC
|
GEN
Gen Digital
|
◎ Target | Saket Kalia ★★★★★ #180 | Equal Weight | $27.00→ $32.00+18.5% |
|
Aug 07
19:34 UTC
|
FUN
Six Flags Entertainment
|
◎ Target | Brandt Montour ★★★☆☆ #1460 | Overweight | $26.00→ $22.00-15.4% |
|
Aug 07
19:34 UTC
|
FTT
Finning International
|
◎ Target | firm only | Outperform | C$118.00→ C$122.00+3.4% |
|
Aug 07
19:34 UTC
|
FTT
Finning International
|
◎ Target | firm only | Outperform | C$115.00→ C$118.00+2.6% |
|
Aug 07
19:34 UTC
|
EVMN
Evommune
|
◎ Target | Brian Abrahams ★★★☆☆ #1865 | Outperform | $30.00→ $29.00-3.3% |
|
Aug 07
19:34 UTC
|
ERO
Ero Copper
|
◎ Target | firm only | Hold | C$44.00→ C$45.00+2.3% |
|
Aug 07
19:34 UTC
|
ERO
Ero Copper
|
◎ Target | firm only | Outperform | C$50.00→ C$52.50+5.0% |
|
Aug 07
19:34 UTC
|
EPR
EPR Properties
|
◎ Target | Michael Carroll ★★★★☆ #894 | Sec→ r Perform | $61.00→ $64.00+4.9% |
|
Aug 07
19:34 UTC
|
EFX
Enerflex
|
◎ Target | firm only | Outperform | C$47.00→ C$48.00+2.1% |
|
Aug 07
19:34 UTC
|
DRVN
Driven Brands
|
◎ Target | Steven Shemesh ★★★★☆ #817 | Outperform | $17.00→ $16.00-5.9% |
|
Aug 07
19:34 UTC
|
DII.B
Dorel Industries
|
◎ Target | firm only | Hold | C$2.00→ C$1.50-25.0% |
|
Aug 07
19:34 UTC
|
DD
DuPont de Nemours
|
◎ Target | Arun Viswanathan ★★★☆☆ #1225 | Outperform | $180.00→ $176.00-2.2% |
|
Aug 07
19:34 UTC
|
DCO
Ducommun
|
◎ Target | Ken Herbert not yet tracked | Sec→ r Perform ➝ Sector Performer | $175.00→ $200.00+14.3% |
|
Aug 07
19:34 UTC
|
DAN
Dana
|
◎ Target | Tom Narayan ★★★☆☆ #1674 | Outperform | $33.00→ $37.00+12.1% |
|
Aug 07
19:34 UTC
|
CYTK
Cytokinetics
|
◎ Target | Leonid Timashev ★★★☆☆ #1437 | Outperform | $117.00→ $112.00-4.3% |
|
Aug 07
19:34 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Ricky Goldwasser not yet tracked | Overweight | $260.00→ $300.00+15.4% |
|
Aug 07
19:34 UTC
|
COR
Cencora
|
◎ Target | Erin Wright ★★★★★ #207 | Overweight | $342.00→ $346.00+1.2% |
|
Aug 07
19:34 UTC
|
CNQ
Canadian Natural Resources
|
◎ Target | firm only | Outperform | C$65.00→ C$66.00+1.5% |
|
Aug 07
19:34 UTC
|
CNQ
Canadian Natural Resources
|
◎ Target | firm only | Buy | C$72.00→ C$73.00+1.4% |
|
Aug 07
19:34 UTC
|
CNQ
Canadian Natural Resources
|
◎ Target | firm only | Sec→ r Perform | C$71.00→ C$73.00+2.8% |
|
Aug 07
19:34 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Judah Frommer ★★★☆☆ #1554 | Overweight | $40.00→ $46.00+15.0% |
|
Aug 07
19:34 UTC
|
CGON
CG Oncology
|
◎ Target | Leonid Timashev ★★★☆☆ #1437 | Outperform | $81.00→ $79.00-2.5% |
|
Aug 07
19:34 UTC
|
CART
Maplebear
|
◎ Target | Ross Sandler ★★★☆☆ #1530 | Overweight | $69.00→ $77.00+11.6% |
|
Aug 07
19:34 UTC
|
CARG
CarGurus
|
◎ Target | Brad Erickson ★★★☆☆ #1886 | Outperform | $35.00→ $42.00+20.0% |
|
Aug 07
19:34 UTC
|
BOS
AirBoss of America
|
◎ Target | firm only | Buy | C$10.00→ C$11.00+10.0% |
|
Aug 07
19:34 UTC
|
BMRN
BioMarin Pharmaceutical
|
◎ Target | Matthew Harrison not yet tracked | Overweight | $119.00→ $124.00+4.2% |
|
Aug 07
19:34 UTC
|
BMBL
Bumble
|
◎ Target | Brad Erickson ★★★☆☆ #1886 | Sec→ r Perform | $5.00→ $4.00-20.0% |
|
Aug 07
19:34 UTC
|
BDX
Becton, Dickinson and Company
|
◎ Target | Kendall Au not yet tracked | Sec→ r Perform | $175.00→ $180.00+2.9% |
|
Aug 07
19:34 UTC
|
BCE
BCE
|
◎ Target | firm only | Sec→ r Outperform | C$39.00→ C$40.00+2.6% |
|
Aug 07
19:34 UTC
|
BCE
BCE
|
◎ Target | firm only | Buy | C$43.50→ C$41.00-5.7% |
|
Aug 07
19:34 UTC
|
AUPH
Aurinia Pharmaceuticals
|
◎ Target | Douglas Miehm ★★★☆☆ #1105 | Sec→ r Perform | $15.00→ $16.00+6.7% |
|
Aug 07
19:34 UTC
|
ATS
ATS
|
◎ Target | firm only | Buy | C$52.00→ C$44.00-15.4% |
|
Aug 07
19:34 UTC
|
ATS
ATS
|
◎ Target | firm only | Buy | C$52.00→ C$46.00-11.5% |
|
Aug 07
19:34 UTC
|
ATS
ATS
|
◎ Target | firm only | Outperform | C$46.00→ C$33.00-28.3% |
|
Aug 07
19:34 UTC
|
ATS
ATS
|
◎ Target | firm only | Outperform | C$57.00→ C$42.00-26.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.